UY36062A - COMPOSITIONS DERIVED FROM CYCLODEXTRINE AND BUDESONIDE AND METHODS - Google Patents

COMPOSITIONS DERIVED FROM CYCLODEXTRINE AND BUDESONIDE AND METHODS

Info

Publication number
UY36062A
UY36062A UY0001036062A UY36062A UY36062A UY 36062 A UY36062 A UY 36062A UY 0001036062 A UY0001036062 A UY 0001036062A UY 36062 A UY36062 A UY 36062A UY 36062 A UY36062 A UY 36062A
Authority
UY
Uruguay
Prior art keywords
relates
present
budesonide
cyclodextrine
methods
Prior art date
Application number
UY0001036062A
Other languages
Spanish (es)
Inventor
Maes Paul
Cataldo Didier
Evrard Brigitte
Dufour Gilles
Pascal De Tullio
Original Assignee
Univ Liege
Maes Paul
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liege, Maes Paul filed Critical Univ Liege
Publication of UY36062A publication Critical patent/UY36062A/en

Links

Abstract

La presente invención se refiere a composiciones farmacéuticas novedosas y útiles formuladas con un compuesto de ciclodextrina y un derivado de budesónido para el tratamiento y/o prevención de la enfermedad pulmonar inflamatoria. La presente invención también se refiere a una técnica analítica útil y novedosa para la detección y la cuantificación de HP-ß -CD en solución. Más específicamente, la presente invención se refiere al uso de un análisis de 1H NMR validado para la detección y cuantificación de ciclodextrinas directamente en formulaciones farmacéuticas sin algunas etapas de extracción o separación para formulaciones químicasThe present invention relates to novel and useful pharmaceutical compositions formulated with a cyclodextrin compound and a budesonide derivative for the treatment and / or prevention of inflammatory lung disease. The present invention also relates to a useful and novel analytical technique for the detection and quantification of HP-β-CD in solution. More specifically, the present invention relates to the use of a validated 1 H NMR analysis for the detection and quantification of cyclodextrins directly in pharmaceutical formulations without some extraction or separation steps for chemical formulations.

UY0001036062A 2014-03-28 2015-04-06 COMPOSITIONS DERIVED FROM CYCLODEXTRINE AND BUDESONIDE AND METHODS UY36062A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461972209P 2014-03-28 2014-03-28
EP14132158 2014-03-28

Publications (1)

Publication Number Publication Date
UY36062A true UY36062A (en) 2015-10-30

Family

ID=55970602

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036062A UY36062A (en) 2014-03-28 2015-04-06 COMPOSITIONS DERIVED FROM CYCLODEXTRINE AND BUDESONIDE AND METHODS

Country Status (1)

Country Link
UY (1) UY36062A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11045434B1 (en) 2020-04-01 2021-06-29 UNION therapeutics A/S Niclosamide formulations for treating disease
  • 2015

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11045434B1 (en) 2020-04-01 2021-06-29 UNION therapeutics A/S Niclosamide formulations for treating disease
US11324708B1 (en) 2020-04-01 2022-05-10 UNION therapeutics A/S Niclosamide formulations for treating disease

Similar Documents

Publication Publication Date Title
AU2017260630A1 (en) Detection of lung neoplasia by analysis of methylated DNA
CY1120969T1 (en) CINOXALINE PRODUCTS USEFUL AS FGFR MODE MODIFIERS
CY1119333T1 (en) 2.2-DIFFluoropropionamide derivative from methylated bardoxolone, polymorphic forms and methods of their use
MX2016012509A (en) Composition comprising cyclodextrin and budesonide derivatives for the treatment and prophylaxis of pulmonary inflammations.
UA117289C2 (en) Multispecific antibodies
WO2015119941A3 (en) Genome fractioning
TW201613862A (en) Sulfonic acid derivative compounds as photoacid generators in resist applications
WO2014124334A3 (en) Transthyretin antibodies and uses thereof
WO2016142146A3 (en) Method of detecting avian necrotic enteritis
CY1120759T1 (en) PREPARATION OF DIGLYCOSITE (S, S) -SECOCOSOLARICIRESINOL AND DIGLYCOSITE (R, R) -SECOSOSOLARICIRESINOL
MX2023005452A (en) Amyloid beta detection by mass spectrometry.
EA201891576A1 (en) FUNCTIONALIZED PENTANE ACIDS FOR APPLICATION IN INFECTIONS CAUSED BY THE VIRUS OF THE FLU
EA201791058A1 (en) MORFOLIN- and 1,4-OXAZAZEPAN-AMIDA AS AN AGONISTS OF SOMATOSTATIN RECEPTOR Subtype 4 (SSTR4)
DK3197046T3 (en) Self-biased output booster amplifier as well as its use
EA201890955A1 (en) METHOD OF OBTAINING A TEA PRODUCT
EA201170545A1 (en) APPLICATION OF ORGANIC SOLVENTS IN THE METHOD OF WET GRANULATION OF MOXIFLOXACIN
EP3254300A4 (en) Detecting mass spectrometry based similarity via curve subtraction
UY36062A (en) COMPOSITIONS DERIVED FROM CYCLODEXTRINE AND BUDESONIDE AND METHODS
CL2017000560A1 (en) Formula that includes glycopyrrolate, method and system
FR3030523B1 (en) NOVEL COMPOUNDS OF THE N-ACYLAMINO-AMIDE FAMILY, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF
EA201591449A1 (en) METHODS OF OBTAINING TREATMENT COMPOSITIONS
BR112016022405A2 (en) COMPOSITIONS OF CYCLODEXTRIN AND BUDESONIDE DERIVATIVE AND METHODS
MX2017013454A (en) Detection of nucleic acid molecules.
WO2014172288A3 (en) Digital analyte analysis
BR112018001836A2 (en) preparation containing odor stable octocrene

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20220610